Effect of Antioxidant on Endurance Performance in Healthy Men

NCT ID: NCT00731926

Last Updated: 2008-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

oligomerized litchi fruit extract may enhance the submaximal endurance exercise performance

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Regular physical exercise has many beneficial effects, but it has been reported that strenuous exercise could elevate the production of free radical and other reactive oxygen species (ROS) which eventually injure the tissues and decrease the muscle function.So many kinds of antioxidant supplementations have been tried to decrease the muscle fatigue and enhance the exercise performance. polyphenolic flavonoids abundant in fruits and leafy vegetables have strong antioxidant effect. oligomerized litchi fruit extract has strong antioxidant capacity and higher bioavailability compared to that of grape seed polyphenol. The aim of this study was to determine whether oligomerized litchi fruit extract could induce endurance exercise performance more than Vit C + Vit E mixture or placebo could do. Therefore, we designed double blind randomized controlled trial, setting the change of running time to exhaustion under submaximal treadmill test as the primary endpoint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise Tolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

Oligomerized litchi fruit extract

Intervention Type DIETARY_SUPPLEMENT

100mg at once twice a day for 1 month

2

Group Type ACTIVE_COMPARATOR

VItamin C + Vitamin E mixture

Intervention Type DIETARY_SUPPLEMENT

Vitamin C 400mg + Vitamin E 160IU at once twice a day for 1 month

3

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

twice a day for 1 month

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oligomerized litchi fruit extract

100mg at once twice a day for 1 month

Intervention Type DIETARY_SUPPLEMENT

VItamin C + Vitamin E mixture

Vitamin C 400mg + Vitamin E 160IU at once twice a day for 1 month

Intervention Type DIETARY_SUPPLEMENT

placebo

twice a day for 1 month

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

oligonol; brand name of oligomerized litchi fruit extract

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy men over 20 years old non-smoker

Exclusion Criteria

* BMI\>25 or body fat\>25% he who intakes the antioxidant supplement in recent 2 weeks
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role collaborator

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institute of Complementary Alternative Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sang-chul Lee, professor

Role: PRINCIPAL_INVESTIGATOR

Institute of Complementary Alternative Medicine SNUMC

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-0707-028-212

Identifier Type: -

Identifier Source: org_study_id